^
Association details:
Biomarker:No biomarker
Cancer:Pancreatic Cancer
Drug:sunitinib (c-KIT inhibitor, VEGFR inhibitor, PDGFR inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
05/23/2022
Excerpt:
Pancreatic Neuroendocrine Tumors (Well-Differentiated Grade 1/2)...Preferred Regimens...Sunitinib